Chemo tied to gut microbiome changes and associated cognitive decline
Jul 23, 2024
The findings were independent of chemotherapy-induced inflammation.
Risk of Parkinson’s disease heightened in people with anxiety
Jul 22, 2024
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
In-hospital delirium increases risk for functional disability, cognitive impairment
Jul 11, 2024
The findings were seen among older adults in the six months following a COVID-19 hospitalization.
Models constructed to predict decline over time in MCI, mild dementia
Jul 10, 2024
For a hypothetical patient with MCI, a baseline MMSE of 28 and CSF Aβ1-42 of 925 pg/mL, an MMSE of 20 was predicted after 6.0 years and after 8.6 years with a hypothetical treatment.
Experiencing gratitude tied to longevity in older women
Jul 08, 2024
Higher levels of gratitude were tied to a 9% reduction in all-cause mortality and a 15% reduction in cardiovascular death.
Higher inflammation from early adulthood linked to worse cognition
Jul 08, 2024
Worse executive function and processing speeding were seen with consistently higher or moderate/increasing inflammation.
Self-administered gerocognitive exam improves detection of cognitive issues in primary care
Jul 02, 2024
Detection rates appear to increase during nonacute office visits.